FDA Strengthens Compounding Safety with Cesium Ban And Research Collaboration

FDA has taken additional steps to make drug compounding safer for patients, including a ban on cesium chloride because of “significant safety risks” it poses and a pair of university research collaborations to help further develop a list of bulk drug ingredients that can be safely compounded.

Pharmacistswithmortatandpestle_1200x675

More from Manufacturing

More from Compliance